Bliss GVS Pharma reported a 22 percent increase in consolidated profit to ₹41.45 crore in the second quarter ended September 30, 2018. Bliss GVS Pharma had...
Dr Reddy’s Laboratories Ltd. announced the launch of Atomoxetine Capsules, USP, a therapeutic equivalent generic version of Strattera (atomoxetine) Capsules in the United States market approved...
Zydus Cadila has launched Vardenafil Hydrochloride Tablets (US RLD – LEVITRA Tablets), 2.5 mg, 5 mg, 10 mg, and 20 mg in the US market upon...
Glenmark Pharmaceuticals Ltd., a research-led globally integrated pharmaceutical company, announced the launch of Nourkrin in Russia. Nourkrin is a globally renowned, clinically-proven proteoglycan replacement formula, for...
Telerad Tech, a global healthcare technology company, today announced the launch of a new AI-Powered product – MammoAssist to detect early-stage breast cancer as a Make...
Microsoft India was named Indian Healthcare Artificial Intelligence and Cloud Computing Company of the Year at Frost & Sullivan’s 2018 India Best Practices Awards Banquet in...
Pharma major Lupin Limited reported its financial performance for the second quarter and six months ended September 30th, 2018. These results were taken on record by...
Drug firm Strides Pharma Science Wednesday reported a consolidated net loss of ₹8.70 crore for the quarter ended September 30, 2018. The company had posted a...
With pharmaceutical major Johnson & Johnson (J&J) losing the patent battle in the US court for its popular prostrate cancer drug Zytiga, opportunities for Indian players,...
Glenmark Pharmaceuticals Tuesday said it has received final approval from the US health regulator for the generic version of Derma-Smoothe Topical Oil, used in the treatment...
Active pharmaceutical ingredients (APIs) and drug intermediates maker Divis Laboratories Limited is creating additional capacities by spending as much as ₹15 billion at its existing facilities...
Solara Active Pharma Sciences announced that the Board of Directors of the company at its meeting held on 30 October 2018 has appointed Ronald Tjeerd De...
Drug major Cipla on Monday said it has received final approval from the US health regulator to market Metoprolol tablets, used to treat hypertension and various cardiac...
It’s a high-stakes corporate gamble, full of peril: Johnson & Johnson has turned its iconic, golden-hued baby shampoo clear. The move is part of a sweeping...
Granules India’s US subsidiary has received two observations from the US health regulator following the completion of inspection. “Granules Pharmaceuticals Inc, a wholly-owned foreign subsidiary of...
Copyright © 2024 Medical Buyer